Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Zweegman, Sonja  [Clear All Filters]
Journal Article
Verhagen, H.J.M.P., van Gils, N., Martiañez, T., van Rhenen, A., Rutten, A., Denkers, F., de Leeuw, D.C., Smit, M.A., Tsui, M.-L., Klootwijk, L.L.E. de Vos, et al. (2018). IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.Cell Rep25, 3021-3035.e5.
Zweegman, S., van der Holt, B., Mellqvist, U.-H., Salomo, M., Bos, G.M.J., Levin, M.-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A.W.G., Deenik, W., et al. (2016). Lenalidomide plus melphalan and prednisone, followed by lenalidomide maintenance versus thalidomide plus melphalan and prednisone, followed by thalidomide maintenance; results of the randomised phase 3 HOVON 87/NMSG18 trial.Blood.
Terwijn, M., Zeijlemaker, W., Kelder, A., Rutten, A.P., Snel, A.N., Scholten, W.J., Pabst, T., Verhoef, G., Löwenberg, B., Zweegman, S., et al. (2014). Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia.Plos One9, e107587.
Schuurhuis, G.J., Meel, M.H., Wouters, F., Min, L.A., Terwijn, M., de Jonge, N.A., Kelder, A., Snel, A.N., Zweegman, S., Ossenkoppele, G.J., et al. (2013). Normal Hematopoietic Stem Cells within the AML Bone Marrow Have a Distinct and Higher ALDH Activity Level than Co-Existing Leukemic Stem Cells.Plos One8, e78897.
Sonneveld, P., Asselbergs, E., Zweegman, S., van der Holt, B., Kersten, M.José, Vellenga, E., van Marwijk-Kooy, M., Broyl, A., de Weerdt, O., Lonergan, S., et al. (2014). Phase 2 study of carfilzomib, thalidomide and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma.Blood.
Bringhen, S., Milan, A., D'Agostino, M., Ferri, C., Wäsch, R., Gay, F., Larocca, A., Offidani, M., Zweegman, S., Terpos, E., et al. (2019). Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A Consensus Paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.J Intern Med.
Lokhorst, H.M., van der Holt, B., Cornelissen, J.J., Kersten, M.Jose', van Oers, M., Raymakers, R., Minnema, M.C., Zweegman, S., Bos, G., Schaap, N., et al. (2015). Reduced relapse rate in upfront tandem autologous/reduced intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression free and not of overall survival.Haematologica.
Moshaver, B., Wouters, R.F., Kelder, A., Ossenkoppele, G.J., Westra, G.A.H., Kwidama, Z., Rutten, A.R., Kaspers, G.J.L., Zweegman, S., Cloos, J., et al. (2019). Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.Leuk Res81, 27-34.